Synchrony 2022: Catalyzing Research and Treatments to Benefit Individuals with Neurodevelopmental Disorders including Autism Spectrum Disorders

Heer Nanda; Richard E Frye

doi:10.3390/jpm13030490

Synchrony 2022: Catalyzing Research and Treatments to Benefit Individuals with Neurodevelopmental Disorders including Autism Spectrum Disorders

J Pers Med. 2023 Mar 9;13(3):490. doi: 10.3390/jpm13030490.

Authors

Heer Nanda¹, Richard E Frye^{2

3

4}

Affiliations

¹ University of California, Berkeley, CA 94720, USA.
² Autism Discovery and Treatment Foundation, Phoenix, AZ 85050, USA.
³ Rossignol Medical Center, Phoenix, AZ 85050, USA.
⁴ Southwest Autism Research and Resource Center, Phoenix, AZ 85006, USA.

Abstract

A unique translational medicine conference for research into treatments that can benefit individuals with neurodevelopmental disorders (NDD), including autism spectrum disorder (ASD), has been developed and hosted by The BRAIN Foundation (Pleasanton, CA, USA) since 2019 [...].

Publication types

Editorial

Grants and funding

This research received no external funding.